Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The document advocates for restricting the use of highest-priority antibiotics in EU livestock farming to prevent antimicrobial resistance, arguing that current proposed EU criteria contain a loophole that would allow continued extensive use of these critical drugs.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • The current draft of the delegated act contains a 'dangerous loophole' (Criterion C) that allows antibiotics to be used in livestock if they are deemed 'essential for animal health', which deviates from WHO criteria and could allow the continued extensive use of critically important antimicrobials (CIA HP) in industrial farming.
  • The parliamentary objection seeks to prohibit the use of CIA HP for group treatments of food-producing animals while maintaining the possibility of treating individual animals in emergencies.
  • WHO identifies five classes of 'critically important antimicrobials highest priority' (CIA HP) that require the highest priority in global resistance containment: Cephalosporins (3rd generation and higher), Quinolones (including Fluoroquinolones), Glycopeptides, Macrolides and Ketolides, and Polymyxins (e.g., Colistin).
  • In 2019, Germany used approximately 670 tonnes of antibiotics in livestock farming (meat, milk, and fish production), nearly double the 339 tonnes used for human patients in the same year.
  • Evidence from Denmark and other Scandinavian countries shows that 3rd and 4th generation Cephalosporins are practically no longer used, and Denmark has also ceased the use of Colistin (Polymyxin).
  • High resistance rates are observed in the EU; for example, 82.1% of humans are resistant to Ciprofloxacin, and resistance in Campylobacter is so widespread in most countries that the drug's use for human treatment is limited.

Cite the original document

APA
Tsilimekis, K. (2021). Antibiotika in der Tierhaltung. Germanwatch. https://germanwatch.org/sites/default/files/germanwatch_antibiotika_in_der_tierhaltung_fakten_zur_aktuellen_kontroverse.pdf
Chicago
Tsilimekis, Konstantinos. Antibiotika in der Tierhaltung. Germanwatch, 2021. https://germanwatch.org/sites/default/files/germanwatch_antibiotika_in_der_tierhaltung_fakten_zur_aktuellen_kontroverse.pdf.
Wikipedia
{{cite report |last1=Tsilimekis |first1=Konstantinos |title=Antibiotika in der Tierhaltung |publisher=Germanwatch |date=September 2021 |url=https://germanwatch.org/sites/default/files/germanwatch_antibiotika_in_der_tierhaltung_fakten_zur_aktuellen_kontroverse.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document gerwat-001635)}}
BibTeX
@techreport{tsilimekis2021antibiotika, author = {Tsilimekis, Konstantinos}, title = {{Antibiotika in der Tierhaltung}}, institution = {Germanwatch}, year = {2021}, month = sep, url = {https://germanwatch.org/sites/default/files/germanwatch_antibiotika_in_der_tierhaltung_fakten_zur_aktuellen_kontroverse.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document gerwat-001635} }

Full text

Collected · Record updated